Strategy

Has à la carte genetic medicine arrived?

Read more

Britain looks to life outside the EU

Read more

Who is driving UK biotech investment?

Read more

Targeting diseases of ageing populations

Read more

The power of numbers in genomics research

Read more

Liquid biopsy comes of age

Read more

Outcome data play a bigger role in medicine

Read more

Attacking Zika by modifying mosquitoes

Read more

Rising success for oncology drug development

Read more

How Cellectis developed gene editing for cancer

Read more